In celiac disease, a subset of autoantibodies against transglutaminase binds toll-like receptor 4 and induces activation of monocytes
Giovanna Zanoni, Riccardo Navone, Claudio Lunardi, Giuseppe Tridente, Caterina Bason, Simona Sivori, Ruggero Beri, Marzia Dolcino, Enrico Valletta, Roberto Corrocher, Antonio Puccetti, Giovanna Zanoni, Riccardo Navone, Claudio Lunardi, Giuseppe Tridente, Caterina Bason, Simona Sivori, Ruggero Beri, Marzia Dolcino, Enrico Valletta, Roberto Corrocher, Antonio Puccetti
Abstract
Background: Celiac disease is a small intestine inflammatory disorder with multiple organ involvement, sustained by an inappropriate immune response to dietary gluten. Anti-transglutaminase antibodies are a typical serological marker in patients with active disease, and may disappear during a gluten-free diet treatment. Involvement of infectious agents and innate immunity has been suggested but never proven. Molecular mimicry is one of the mechanisms that links infection and autoimmunity.
Methods and findings: In our attempt to clarify the pathogenesis of celiac disease, we screened a random peptide library with pooled sera of patients affected by active disease after a pre-screening with the sera of the same patients on a gluten-free diet. We identified a peptide recognized by serum immunoglobulins of patients with active disease, but not by those of patients on a gluten-free diet. This peptide shares homology with the rotavirus major neutralizing protein VP-7 and with the self-antigens tissue transglutaminase, human heat shock protein 60, desmoglein 1, and Toll-like receptor 4. We show that antibodies against the peptide affinity-purified from the sera of patients with active disease recognize the viral product and self-antigens in ELISA and Western blot. These antibodies were able to induce increased epithelial cell permeability evaluated by transepithelial flux of [(3)H] mannitol in the T84 human intestinal epithelial cell line. Finally, the purified antibodies induced monocyte activation upon binding Toll-like receptor 4, evaluated both by surface expression of activation markers and by production of pro-inflammatory cytokines.
Conclusions: Our findings show that in active celiac disease, a subset of anti-transglutaminase IgA antibodies recognize the viral protein VP-7, suggesting a possible involvement of rotavirus infection in the pathogenesis of the disease, through a mechanism of molecular mimicry. Moreover, such antibodies recognize self-antigens and are functionally active, able to increase intestinal permeability and induce monocyte activation. We therefore provide evidence for the involvement of innate immunity in the pathogenesis of celiac disease through a previously unknown mechanism of engagement of Toll-like receptor 4.
Conflict of interest statement
Competing Interests: The authors have declared that no competing interests exist.
Figures
References
- Hadjivassiliou M, Williamson CA, Woodroofe N. The immunology of gluten sensitivity: Beyond the gut. Trends Immunol. 2004;25:578–582.
- Dewar DH, Ciclitira PJ. Clinical features and diagnosis of celiac disease. Gastroenterology. 2005;128:S19–S24.
- MacDonald TT, Monteleone G. Immunity, inflammation, and allergy in the gut. Science. 2005;307:1920–1925.
- Rewers M. Epidemiology of celiac disease: What are the prevalence, incidence, and progression of celiac disease ? Gastroenterology. 2005;128:S47–S51.
- Rostom A, Dube C, Cranney A, Saloojee N, Sy R, et al. The diagnostic accuracy of serologic tests for celiac disease: A systematic review. Gastroenterology. 2005;128:S38–S46.
- Bazzigaluppi E, Roggero P, Parma B, Brambillasca MF, Meroni F, et al. Antibodies to recombinant human tissue-transglutaminase in celiac disease: Diagnostic effectiveness and decline pattern after gluten-free diet. Dig Liver Dis. 2006;38:98–102.
- Maiuri L, Ciacci C, Ricciardelli I, Vacca L, Raia V, et al. Association between innate response to gliadin and activation of pathogenic T cells in coeliac disease. Lancet. 2003;362:30–37.
- Londei M, Ciacci C, Ricciardelli I, Vacca L, Quaratino S, et al. Gliadin as a stimulator of innate responses in celiac disease. Mol Immunol. 2005;42:913–918.
- Sollid LM, Gray GM. A role for bacteria in celiac disease? Am J Gastroenterol. 2004;99:905–906.
- Kagnoff MF. Overview and pathogenesis of celiac disease. Gastroenterology. 2005;128:S10–S18.
- DeMeo MT, Mutlu EA, Keshavarzian A, Tobin MC. Intestinal permeation and gastrointestinal disease. J Clin Gastroenterol. 2002;34:385–396.
- Schulzke JD, Bentzel CJ, Schulzke I, Riecken EO, Fromm M. Epithelial tight junction structure in the jejunum of children with acute and treated celiac sprue. Pediatr Res. 1998;43:435–441.
- Blutt SE, Crawford SE, Warfield KL, Lewis DE, Estes MK, et al. The VP7 outer capsid protein of rotavirus induces polyclonal B-cell activation. J Virol. 2004;78:6974–6981.
- Dieterich W, Ehnis T, Bauer M, Donner P, Volta U, et al. Identification of tissue transglutaminase as the autoantigen of celiac disease. Nat Med. 1997;3:797–801.
- Pockley AG. Heat shock proteins as regulators of the immune response. Lancet. 2003;362:469–476.
- Amagai M. Desmoglein as a target in autoimmunity and infection. J Am Clin Dermatol. 2003;4:165–175.
- Goldstein DR. Toll-like receptors and other links between innate and acquired alloimmunity. Curr Opin Immunol. 2004;16:538–544.
- Janssens S, Beyaert R. Role of Toll-like receptors in pathogen recognition. Clin Microbiol Rev. 2003;16:637–646.
- Oberhuber G, Granditsch G, Vogelsang H. The histopathology of coeliac disease: Time for a standardized report scheme for pathologists. Eur J Gastroenterol Hepatol. 1999;10:1185–1194.
- Wills AJ. The neurology and neuropathology of celiac disease. Neuropathol Appl Neurobiol. 2000;26:473–476.
- Volta U, De Giorgio R, Petrolini N, Stangbellini V, Barnaba G, et al. Clinical findings and anti-neuronal antibodies in celiac disease with neurological disorders. Scand J Gastroenterol. 2002;37:1276–1281.
- Oliveri M, Daga A, Lunardi C, Navone R, Millo R, et al. Dnase I behaves as a transcription factor which modulates Fas expression in human cells. Eur J Immunol. 2004;34:273–279.
- Lunardi C, Bason C, Navone R, Millo E, Damonte G, et al. Systemic sclerosis immunoglobulin G autoantibodies bind the human cytomegalovirus late protein UL94 and induce apoptosis in human endothelial cells. Nat Med. 2000;6:1183–1186.
- Lunardi C, Bason C, Leandri M, Navone R, Lestani M, et al. Autoantibodies to inner ear and endothelial antigens in Cogan syndrome. Lancet. 2001;360:915–921.
- Navone R, Lunardi C, Gerli R, Tinazzi E, Peterlana D, et al. Identification of tear lipocalin as a novel autoantigen target in Sjogren's syndrome. J Autoimmunity. 2005;25:229–234.
- Puccetti A, Bason C, Simeoni S, Millo E, Tinazzi E, et al. In chronic idiopathic urticaria autoantibodies against Fc epsilonRII/CD23 induce histamine eosinophil activation. Clin Exp Allergy. 2005;35:1599–1607.
- Wellings DA, Atherton E. Standard FMOC protocols. Meth Enzymol. 1997;289:44–67.
- Schindler U, Baichwal VR. Three NF-kB binding sites in the human E-selectin gene required for maximal tumour necrosis factor alpha-induced expression. Mol Cell Biol. 1994;14:5820–5831.
- Laporte J, Bedez F, Bolino A, Mandel JL. Myotubularins, a large disease-associated family of cooperating catalytically active and inactive phosphoinositides phosphatases. Hum Molec Genet. 2003;12:285–292.
- Freitag T, Schulze-Koops H, Niedobitek G, Melino G, Schuppan D. The role of immune response against tissue transglutaminase in the pathogenesis of coeliac disease. Autoimmunity Rev. 2004;3:13–20.
- Seissler J, Wolhrab U, Wuensche WA, Scherbaum A, Boehm O. Autoantibodies from patients with celiac disease recognize distinct functional domains of the autoantigen tissue transglutaminase. Clin Exp Immunol. 2001;125:216–221.
- Halttunen T, Mäki M. Serum Immunoglobulin A from patients with celiac disease inhibits human T84 intestinal crypt epithelial cell differentiation. Gastroenterology. 1999;116:586–572.
- Clark B, McKendrick M. A review of viral gastroenteritis. Curr Opin Infect Dis. 2004;17:461–469.
- Wucherpfennig KW, Strominger JL. Molecular mimicry in T cell-mediated autoimmunity: Viral peptides activate human T cell clones specific for myelin basic protein. Cell. 1995;80:695–705.
- Zhao ZS, Granucci F, Yeh L, Schaffer PA, Cantor H. Molecular mimicry by herpes symplex virus-type 1: Autoimmune disease after viral infection. Science. 1998;279:1344–1347.
- Lunardi C, Bason C, Corrocher R, Puccetti A. Induction of endothelial cell damage by hCMV molecolar mimicry. Trends Immunol. 2005;26:19–24.
- Honeyman MC, Coulson BS, Stone NL, Shane AG, Goldwater PN, et al. Association between Rotavirus infection and pancreatic islet autoimmunity in children at risk of developing type I diabetes. Diabetes. 2000;49:1319–1324.
- Honeyman MC, Stone NL, Harrison LC. T-cell epitopes in type I diabetes autoantigen tyrosine phosphatase IA-2: Potential for mimicry with rotavirus and other environmental agents. Mol Med. 1998;4:231–239.
- Wildner G, Diedrichs-Mohring M. Autoimmune uveitis induced by molecular mimicry of peptides from rotavirus, bovine casein and retinal S-antigen. Eur J Immunol. 2003;33:2577–2587.
- Nakachi K, Powell M, Swift G, Amoroso MA, Ananieva-Jordanova R, et al. Epitope recognized by tissue transglutaminase antibodies in celiac disease. J Autoimm. 2004;22:53–63.
- Iltanen S, Rantala I, Laippala P, Holm K, Partanen J, et al. Expression of HSP-65 in jejunal epithelial cells in patients clinically suspected of coeliac disease. Autoimmunity. 1999;31:125–132.
- Bolino A, Muglia M, Conforti FL, LeGuern E, Salih MA, et al. Charcot-Marie-Tooth type 4B is caused by mutations in the gene encoding myotubularin-related protein-2. Nat Genet. 2000;25:17–19.
- Waldner H, Collins M, Kuchroo VK. Activation of antigen-presenting cells by microbial products breaks self tolerance and induces autoimmune disease. J Clin Invest. 2004;113:990–997.
- Manfredi AA, Sabbadini MG, Rovere-Querini P. Dendritic cells and the shadow line between autoimmunity and disease. Arthritis Rheum. 2005;52:11–15.
Source: PubMed